Zimmer Biomet Holdings Inc (ZBH) Shares Bought by Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp

Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp grew its stake in Zimmer Biomet Holdings Inc (NYSE:ZBH) by 67.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 100,000 shares of the medical equipment provider’s stock after purchasing an additional 40,300 shares during the quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp’s holdings in Zimmer Biomet were worth $12,067,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of the company. Armor Investment Advisors LLC raised its position in shares of Zimmer Biomet by 11.7% in the fourth quarter. Armor Investment Advisors LLC now owns 3,830 shares of the medical equipment provider’s stock valued at $463,000 after purchasing an additional 400 shares during the period. Daiwa SB Investments Ltd. increased its position in Zimmer Biomet by 5.2% during the fourth quarter. Daiwa SB Investments Ltd. now owns 8,470 shares of the medical equipment provider’s stock worth $1,022,000 after acquiring an additional 420 shares during the period. Financial Counselors Inc. increased its position in Zimmer Biomet by 5.2% during the fourth quarter. Financial Counselors Inc. now owns 8,709 shares of the medical equipment provider’s stock worth $1,051,000 after acquiring an additional 431 shares during the period. Creative Planning increased its position in Zimmer Biomet by 2.9% during the fourth quarter. Creative Planning now owns 15,765 shares of the medical equipment provider’s stock worth $1,902,000 after acquiring an additional 443 shares during the period. Finally, Dorsey & Whitney Trust CO LLC increased its position in Zimmer Biomet by 0.9% during the fourth quarter. Dorsey & Whitney Trust CO LLC now owns 49,118 shares of the medical equipment provider’s stock worth $5,926,000 after acquiring an additional 447 shares during the period. 86.49% of the stock is currently owned by institutional investors.

How to Become a New Pot Stock Millionaire

Shares of Zimmer Biomet Holdings Inc (ZBH) opened at $111.38 on Friday. Zimmer Biomet Holdings Inc has a one year low of $108.03 and a one year high of $133.49. The company has a quick ratio of 0.81, a current ratio of 1.50 and a debt-to-equity ratio of 0.76. The firm has a market cap of $23,235.94, a P/E ratio of 14.24, a PEG ratio of 1.99 and a beta of 1.13.

Zimmer Biomet (NYSE:ZBH) last posted its quarterly earnings results on Tuesday, January 30th. The medical equipment provider reported $2.10 earnings per share for the quarter, meeting analysts’ consensus estimates of $2.10. Zimmer Biomet had a net margin of 23.51% and a return on equity of 15.45%. The company had revenue of $2.07 billion for the quarter, compared to the consensus estimate of $2.03 billion. During the same period last year, the company posted $2.14 EPS. The firm’s quarterly revenue was up 3.0% compared to the same quarter last year. sell-side analysts anticipate that Zimmer Biomet Holdings Inc will post 7.8 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, April 30th. Stockholders of record on Thursday, March 29th will be paid a $0.24 dividend. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.86%. Zimmer Biomet’s payout ratio is currently 10.65%.

In other Zimmer Biomet news, insider Bryan C. Hanson bought 25,077 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were acquired at an average cost of $119.68 per share, for a total transaction of $3,001,215.36. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Chad F. Phipps sold 20,826 shares of Zimmer Biomet stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $115.95, for a total transaction of $2,414,774.70. The disclosure for this sale can be found here. Company insiders own 1.07% of the company’s stock.

ZBH has been the topic of a number of recent research reports. Canaccord Genuity reaffirmed a “hold” rating and set a $125.00 price target on shares of Zimmer Biomet in a research report on Tuesday, December 19th. Goldman Sachs raised shares of Zimmer Biomet from a “sell” rating to a “neutral” rating and set a $125.00 price target on the stock in a research report on Tuesday, December 19th. Oppenheimer reiterated a “buy” rating on shares of Zimmer Biomet in a research note on Tuesday, December 19th. Wells Fargo upgraded shares of Zimmer Biomet from a “market perform” rating to an “outperform” rating in a research note on Tuesday, December 19th. Finally, ValuEngine upgraded shares of Zimmer Biomet from a “hold” rating to a “buy” rating in a research note on Thursday, January 11th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $140.63.

TRADEMARK VIOLATION NOTICE: This article was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international copyright law. The legal version of this article can be read at https://www.tickerreport.com/banking-finance/3291583/zimmer-biomet-holdings-inc-zbh-shares-bought-by-her-majesty-the-queen-in-right-of-the-province-of-alberta-as-represented-by-alberta-investment-management-corp.html.

Zimmer Biomet Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

FCB Financial  Earns Daily News Impact Score of 0.12
FCB Financial Earns Daily News Impact Score of 0.12
Under Armour  Upgraded by Deutsche Bank to Hold
Under Armour Upgraded by Deutsche Bank to Hold
Verizon Communications  Rating Increased to Overweight at Barclays
Verizon Communications Rating Increased to Overweight at Barclays
Zacks Investment Research Upgrades WEC Energy Group  to Buy
Zacks Investment Research Upgrades WEC Energy Group to Buy
Watsco  PT Set at $185.00 by Stephens
Watsco PT Set at $185.00 by Stephens
Ashford  Stock Rating Lowered by Zacks Investment Research
Ashford Stock Rating Lowered by Zacks Investment Research


© 2006-2018 Ticker Report. Google+.